We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

102 hedge funds and large institutions have $1.06B invested in Heron Therapeutics in 2015 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 43 increasing their positions, 19 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

202% more call options, than puts

Call options by funds: $127M | Put options by funds: $41.9M

126% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 19

115% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 13

16% more funds holding

Funds holding: 88 → 102 (+14)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

5% less capital invested

Capital invested by funds: $1.13B → $1.06B (-$61M)

Holders
102
Holders Change
+14
Holders Change %
+15.91%
% of All Funds
2.85%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
28
Increased
43
Reduced
19
Closed
13
Calls
$127M
Puts
$41.9M
Net Calls
+$84.8M
Net Calls Change
+$4.85M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$119M
2
Invesco
Invesco
Georgia
+$75.6M
3
JHIU
Janus Henderson Investors US
Colorado
+$40.9M
4
PHS
PFM Health Sciences
California
+$38.4M
5
Goldman Sachs
Goldman Sachs
New York
+$24M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$23.7M
2
BC
Broadfin Capital
New York
-$17.8M
3
Franklin Resources
Franklin Resources
California
-$17.4M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$15.5M
5
PA
Perceptive Advisors
New York
-$14M
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$4.21M +$5.76M +172,689 New
Asset Management One
27
Asset Management One
Japan
$4.01M +$693K +20,808 +12%
SM
28
Sabby Management
Florida
$3.91M +$5.34M +160,323 New
HCM
29
Highbridge Capital Management
New York
$3.89M +$5.32M +159,571 New
Allianz Asset Management
30
Allianz Asset Management
Germany
$3.83M -$9.4M -282,185 -64%
TA
31
Teachers Advisors
New York
$3.71M +$3.85M +115,624 +317%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$2.94M +$181K +5,441 +5%
LOAMU
33
Lombard Odier Asset Management (USA)
New York
$2.87M -$2.42M -72,500 -38%
Adage Capital Partners
34
Adage Capital Partners
Massachusetts
$2.8M +$3.82M +114,700 New
TCIM
35
TIAA CREF Investment Management
New York
$2.75M +$420K +12,595 +13%
Deutsche Bank
36
Deutsche Bank
Germany
$2.52M -$2.06M -61,848 -37%
BIM
37
BlackRock Investment Management
Delaware
$2.5M +$497K +14,920 +17%
DCM
38
Driehaus Capital Management
Illinois
$2.45M -$2.47M -74,089 -42%
TI
39
Turner Investments
Pennsylvania
$2.16M +$1.13M +33,880 +62%
Charles Schwab
40
Charles Schwab
California
$2.15M +$1.45M +43,556 +98%
PAM
41
Panagora Asset Management
Massachusetts
$2.1M +$378K +11,342 +15%
Citigroup
42
Citigroup
New York
$1.92M +$2.51M +75,181 +2,123%
Morgan Stanley
43
Morgan Stanley
New York
$1.92M -$5.01M -150,465 -66%
TCM
44
Tamarack Capital Management
California
$1.83M +$2.5M +75,000 New
ARTA
45
A.R.T. Advisors
New York
$1.74M +$2.37M +71,138 New
D.E. Shaw & Co
46
D.E. Shaw & Co
New York
$1.47M -$5.62M -168,657 -74%
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$1.3M +$273K +8,200 +18%
Voloridge Investment Management
48
Voloridge Investment Management
Florida
$1.28M -$1.22M -36,658 -41%
PIM
49
Partner Investment Management
California
$1.27M +$751K +22,542 +77%
SFM
50
Sphera Funds Management
Israel
$1.22M +$1.67M +50,000 New
1
2
3 4 5

HRTX Hedge Fund Activity: Q3 2015 in Review

102 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q3 2015, worth a combined $1.06B — down 5.4% from $1.13B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new HRTX positions and 13 closed out — a net gain of 15 holders — while 43 added to existing stakes and 19 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $119M. The largest seller was Millennium Management, exiting entirely with an estimated $23.7M sold.

  • 102 institutional investors held Heron Therapeutics (HRTX) as of Q3 2015, up from 88 in Q2 2015.
  • Funds reported $1.06B of Heron Therapeutics stock for Q3 2015, down 5.4% quarter-over-quarter.
  • 28 funds opened new Heron Therapeutics positions in Q3 2015 and 13 closed out, a net change of +15 holders.
  • The largest Heron Therapeutics buyer in Q3 2015 was Fidelity Investments, an estimated $119M added.
  • The largest Heron Therapeutics seller in Q3 2015 was Millennium Management, an estimated $23.7M sold.

Based on aggregated 13F filings for Q3 2015.